Chimeric Antigen Receptor-Modified T Cells for Breast Cancer
Clinical trial NCT02547961 · WITHDRAWN
Trial details
- NCT number
- NCT02547961
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-08-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.